Compass Pathways CEO on completing world's largest psychedelic therapy trial to treat depression

In this article:

George Goldsmith, Compass Pathways CEO, joins Yahoo Finance to discuss the company’s completion of the world’s largest psychedelic therapy trial to date for treating depression and outlook for the psychedelics industry.

Advertisement